Tandem Diabetes Care traded at $60.85 this Monday June 27th, decreasing $0.68 or 1.10 percent since the previous trading session. Looking back, over the last four weeks, Tandem Diabetes Care lost 10.75 percent. Over the last 12 months, its price fell by 38.84 percent. Looking ahead, we forecast Tandem Diabetes Care to be priced at 59.87 by the end of this quarter and at 55.16 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
60.85
Daily Change
-1.10%
Yearly
-38.84%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 255.82 0.50 0.20% -18.12%
Abbott 108.79 -0.66 -0.60% -5.97%
Align Technology 251.22 -7.53 -2.91% -59.58%
Accuray 2.11 0.05 2.43% -54.23%
AtriCure 41.24 0.32 0.78% -48.34%
Natus Medical 32.87 0.22 0.67% 11.42%
Baxter International 67.29 0.51 0.76% -17.59%
Becton, Dickinson and Co. 249.97 -0.95 -0.38% 2.57%
Boston Scientific 37.95 -0.07 -0.18% -12.42%
Cooper Companies 321.52 -1.97 -0.61% -18.71%
Cardiovascular Systems 15.00 0.03 0.20% -65.93%
Dexcom 76.94 -0.73 -0.94% -81.99%
Edwards Lifesciences 96.65 -0.33 -0.34% -5.78%
Globus Medical 58.62 0.77 1.33% -22.95%
Integra LifeSciences 55.09 0.60 1.09% -19.61%
ICU Medical 169.47 0.05 0.03% -17.49%
Inogen 25.59 -0.57 -2.18% -61.43%
Intuitive Surgical 208.45 -1.22 -0.58% -77.15%
J&J 182.58 0.29 0.16% 11.32%
Eli Lilly 327.97 2.35 0.72% 43.71%
Masimo 140.64 2.04 1.47% -43.34%
Medtronic 90.93 0.71 0.79% -26.52%
Merit Medical Systems 54.26 1.32 2.49% -15.55%
NuVasive 50.55 -0.12 -0.24% -27.67%
Orthofix International 24.35 -0.12 -0.49% -41.69%
Insulet 226.15 -1.58 -0.69% -18.75%
Roche Holding 321.40 2.60 0.82% -7.66%
Stryker 203.88 -0.55 -0.27% -21.69%
Teleflex 258.78 0.73 0.28% -36.32%
Tandem Diabetes Care 60.85 -0.68 -1.10% -38.84%
Zimmer Biomet Holdings Inc 108.67 -0.20 -0.18% -33.62%

Indexes Price Day Year
USND 11609 1.58 0.01% -19.94%
US2000 1781 15.14 0.86% -23.32%

Tandem Diabetes Care
Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercialization of products for people with insulin-dependent diabetes. The Company’s manufacturing, sales and support activities principally focus on its flagship pump platform, the t:slim X2 Insulin Delivery System (t:slim X2), and its product offerings. The t:slim X2 is based on its technology platform and is capable of remote feature updates and is designed to display continuous glucose monitoring (CGM) sensor information directly on the pump home screen. Its products also include Basal-IQ technology and Control-IQ technology. The Basal-IQ technology is a predictive low glucose suspend feature that is designed to temporarily suspend insulin delivery to help reduce the frequency and duration of hypoglycemic events. Its Control-IQ technology is a hybrid-closed loop feature, designed to help increase a user's time in targeted glycemic range.